ExploreInsights

Karen Hong

Director

Karen Hong is currently a partner at Novo Ventures (US), Inc. Prior to Novo Ventures, Dr. Hong was a Senior Investment Director at Takeda Ventures, Inc. based in Cambridge, MA. Prior to TVI, she was a Partner at ProQuest Investments. She has served on the Board of Directors of Obsidian Therapeutics, Palleon Pharmaceuticals, Clarus Therapeutics, ...


Social

Roles at Cyteir Therapeutics

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.